Zydus receives tentative approval from US FDA for Empagliflozin and Linagliptin tablets
Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (US FDA) for Empagliflozin…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Ahmadabad
Emcure Pharma inaugurates R&D centre in Ahmedabad
The Emcure Research Centre (ERC) aims to enable breakthroughs in complex drug delivery systems, such as sustained-release…
Amneal pharma expands operations in India with two new manufacturing facilities
Amneal to invest up to $200 million for advanced peptide synthesis and sterile fill-finish facilities in Ahmedabad
Zydus receives final US FDA nod for Valsartan Tablets
Valsartan tablets had annual sales of $149.5 mn in the United States (IQVIA MAT May 2024)
B&R India organises Innovation Day event in Ahmedabad
A panel discussion explored various aspects involved in successful digital transformation and ways to ensure long-term RoI…
Gujarat FDCA seizes spurious drug of Torrent Pharma’s Losar-H brand
Losar-H tablet is a combination medicine used for treatment of high blood pressure. The spurious drug was sold at 50 per cent of…
Bosch Rexroth appoints Hans Bangert as MD
He joined Bosch in 1982 and has since then successfully established and led many innovative projects
Troikaa’s Dynapar QPS bags National Award
The award was given to Troikaa’s novel technology for topical drug delivery which is commercialised under the brand name Dynapar…
Torrent Pharma announces Q4 & FY 2014-15 results
For Q4 FY 2014-15, revenues were at Rs 1,154 crores down by six per cent from Rs 1,225 crores
Ahmedabad-based Torrent…